Klimiuk Joanna, Domagała-Kulawik Joanna, Krenke Rafał, Chazan Ryszarda
Katedra i Klinika Chorób Wewnetrznych Pneumonologii i Alergologii AM w Warszawie.
Pol Arch Med Wewn. 2004 Mar;111(3):291-6.
The role of lymphocytes in host defence in neoplastic disorders is known. Accumulation of lymphocytes in pleural cavity frequently occurs in different diseases. The aim of the study was to evaluate: 1) the frequency of lymphocyte predominance in different malignant and non-malignant pleural effusions; 2) lymphocyte phenotype and the ratio between helper (CD4+) and cytotoxic/suppressor (CD8+) lymphocytes in malignant and non-malignant effusions. Patients with mesothelioma, lung cancer, lymphoma and metastatic neoplasms were analysed. Analysis was performed on fluids with or without malignant cells. Non-malignant fluids were obtained from patients with: congestive heart failure, liver cirrhosis, pneumonia and tuberculosis. Lymphocytes were the predominant cell type in neoplastic effusions. For further analysis effusions with more than 10% of lymphocytes were included: 12 malignant and 9 non-malignant. For lymphocyte subpopulations analysis, the monoclonal antibodies anti-CD4 and anti-CD8 and APAAP method was used. We observed lower percentage of CD4+ lymphocytes (47%) and higher percentage of CD8+ (39%) lymphocytes in malignant when compared to non-malignant fluids (58% vs 31% respectively). The CD4+/CD8+ ratio was significantly lower in pleural fluid in cases with neoplastic disease when compared to benign cause of pleural involvement (1.03 vs 1.85). Our observations suggest the potential role of lymphocytes, especially CD8+ cells in local response in malignancy in pleural disease.
淋巴细胞在肿瘤性疾病宿主防御中的作用已为人所知。淋巴细胞在胸腔积液中的积聚在不同疾病中经常发生。本研究的目的是评估:1)不同恶性和非恶性胸腔积液中淋巴细胞占优势的频率;2)恶性和非恶性胸腔积液中淋巴细胞表型以及辅助性(CD4+)和细胞毒性/抑制性(CD8+)淋巴细胞之间的比例。对间皮瘤、肺癌、淋巴瘤和转移性肿瘤患者进行了分析。对含有或不含有恶性细胞的液体进行了分析。非恶性液体取自患有充血性心力衰竭、肝硬化、肺炎和肺结核的患者。淋巴细胞是肿瘤性胸腔积液中的主要细胞类型。为进行进一步分析,纳入了淋巴细胞比例超过10%的胸腔积液:12例恶性和9例非恶性。对于淋巴细胞亚群分析,使用了抗CD4和抗CD8单克隆抗体以及碱性磷酸酶抗碱性磷酸酶(APAAP)法。我们观察到,与非恶性液体相比(分别为58%和31%),恶性液体中CD4+淋巴细胞的百分比更低(47%),CD8+淋巴细胞的百分比更高(39%)。与良性胸腔受累原因相比,肿瘤性疾病患者胸腔积液中的CD4+/CD8+比值显著更低(1.03对1.85)。我们的观察结果表明淋巴细胞,尤其是CD8+细胞在胸膜疾病恶性肿瘤局部反应中的潜在作用。